methoxyhydroxyphenylglycol has been researched along with Atherosclerotic Parkinsonism in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloem, BR; Herbert, MK; Kuiperij, H; Verbeek, MM | 1 |
| Abi-Dargham, A; Baldwin, RM; Bowers, MB; Charney, DS; D'Souza, CD; Fingado, CL; Innis, RB; Jatlow, P; Kanes, SJ; Laruelle, M; Seibyl, JP; Zoghbi, SS | 1 |
| Arnold, LA; Blanchet, PJ; Chase, TN; Hyland, K; Konitsiotis, S; Pettigrew, KD | 1 |
| Aigner, TG; Cohen, RM; Doudet, DJ; McLellan, CA | 1 |
| Balottin, U; Borgatti, R; Lanzi, G; Zambrino, CA | 1 |
| Burns, RS; Ebert, MH; Kopin, IJ; LeWitt, PA; Pakkenberg, H | 1 |
| Bankiewicz, K; Harvey-White, J; Kopin, IJ | 1 |
7 other study(ies) available for methoxyhydroxyphenylglycol and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.
Topics: Aged; Cerebrovascular Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary | 2013 |
Imaging D2 receptor occupancy by endogenous dopamine in humans.
Topics: Adult; Affect; alpha-Methyltyrosine; Animals; Benzamides; Brain; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Humans; Iodine Radioisotopes; Male; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tyrosine 3-Monooxygenase | 1997 |
Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Biopterins; Disease Models, Animal; Female; Free Radical Scavengers; Homovanillic Acid; Indans; Macaca fascicularis; Male; Methoxyhydroxyphenylglycol; Motor Activity; Parkinson Disease, Secondary; Pilot Projects; Piperazines | 1998 |
Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Receptors, Dopamine; Tomography, Emission-Computed | 1992 |
Consideration on two cases of dystonia-parkinsonism.
Topics: Carbidopa; Child; Dystonia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary | 1991 |
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Substance-Related Disorders; Substantia Nigra; Syndrome | 1985 |
Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Creatinine; Debrisoquin; Female; Glycols; Homovanillic Acid; Isoquinolines; Macaca mulatta; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Pyridines; Regression Analysis | 1988 |